| 查看: 1165 | 回复: 1 | |||
frankeyfeng新虫 (初入文坛)
|
[交流]
UTSW 招聘博后 已有1人参与
|
|
Postdoctoral Position in Cytokine Therapy at the Gao Lab, UT Southwestern Medical Center (Post date: January 2025) The Gao Lab at UT Southwestern Medical Center is seeking a motivated and talented postdoctoral fellow to join our team. This position offers an exciting opportunity to work on immune engineering projects in cytokine therapy and contribute to transformative cancer research. Position Overview Title: Postdoctoral Fellow (Cytokine Therapy) Key responsibilities: (1) Protein engineering design to develop novel cytokines for nanoparticle encapsulation; (2) Pharmacokinetic and pharmacodynamic evaluations of cytokine therapies; (3) Investigate the pharmacological and immunological mechanisms underlying cytokine therapies. Qualifications: A doctoral degree (or near completion) in one of the following fields: protein engineering, cytokines (IL-2 or IL-12), immunology, or pharmacology. Strong research skills and a passion for advancing therapeutic innovation. To apply, please send your CV to: Dr. Jinming Gao: jinming.gao@utsouthwestern.edu or Dr. Qiang Feng: qiang.feng@utsouthwestern.edu. Important Note: Please do not include compressed files (e.g., zip files) in email attachments. About the Gao Lab Dr. Jinming Gao and his group study the science of nanotechnology and cancer. Through molecular cooperativity, his group innovate nanotechnology platforms to target cancer hallmarks with the goal to transform patient care. In cancer diagnosis, the Gao Group designed proton transistor nanoparticles that digitize tumor acidotic signals from dysregulated cancer cell metabolism (Warburg effect). Pegsitacianine, one such nanosensor, received Breakthrough Therapy Designation in cytoreductive surgery of peritoneal metastasis. In cancer therapy, Gao Group discovered synthetic polymers for non-canonical activation of stimulator of interferon genes (STING) pathway with improved tumor and cell selectivity and antitumor immunity over small molecule agonists. A nanoparticle STING agonist has entered first-in-human trials in 2023. The cytokine project is newly funded research area integrating protein and nanoengineering efforts to advance cytokine immunotherapy with strong translational potential. Dr. Gao is a fellow of the National Academy of Inventors and American Institute of Medical and Biological Engineering. He is a recipient of the Outstanding Investigator Award from the National Cancer Institute. UT Southwestern Medical Center at Dallas is a premiere medical institution leading basic and translational research in the US. Lab website: https://labs.utsouthwestern.edu/gao-lab |
回复此楼» 猜你喜欢
工科调剂
已经有3人回复
-
0856化学工程280分求调剂
已经有3人回复
-
0703化学一志愿211 总分320求调剂
已经有4人回复
-
271求调剂
已经有8人回复
-
材料与化工085600调剂求老师收留
已经有8人回复
-
277求调剂
已经有4人回复
-
【0703化学调剂】-一志愿华中师范大学-六级475
已经有3人回复
-
求调剂
已经有6人回复
-
【0856】化学工程（085602）313 分，本科学科评估A类院校化学工程与工艺，诚求调剂
已经有6人回复
-
材料调剂，307分
已经有17人回复
2楼2025-02-07 15:32:16
